Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

TSXV/NTLX stock hub

TSXV/NTLX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/NTLXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22.1M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/NTLX

In the news

Latest news · TSXV/NTLX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-399.2

P25 -121.5P50 -40.9P75 0.5

ROIC-109.7

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/NTLX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

126

Groups with data

Currency

CAD

Showing 126 of 126 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 22M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	CAD 22.1M
Price	CAD 0.26
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/NTLX
Website	https://www.neurothera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.61%
EV Earnings	-3.89x
EV/Sales	18.72x
P/B ratio	24.84x
P/S ratio	18.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-297.08%
Gross margin	73.71%
Gross Profit	CAD 865,177
Net Income	CAD -5.7M
Pretax Margin	-507.48%
ROA	-71.32
ROCE	-165.4
ROE	-399.2
ROIC	-109.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	73.4%
Cagr3y	29.39%
Revenue Growth	-34.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.36
Assets	CAD 4.2M
Cash	CAD 2.3M
Current Assets	CAD 2.5M
Current Liabilities	CAD 1.9M
Debt	CAD 1.3M
Debt Equity	CAD 1.44
Equity	CAD 888,486
Interest Coverage	-21.9
Liabilities	CAD 3.3M
Long Term Assets	CAD 1.6M
Long Term Liabilities	CAD 1.4M
Net Cash	CAD 1.1M
Net Cash By Market Cap	CAD 4.76
Net Debt Equity	CAD -1.18
Tangible Book Value	CAD -1.4M
WACC	3.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.35
Inventory Turnover	2.39
Net Working Capital	CAD -1.2M
Quick ratio	1.29
Working Capital	CAD 664,993

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	73.33%
3Y total return	116.67%
All Time High	0.26
All Time High Change	0%
All Time High Date	2021-12-13
All Time Low	0.12
All Time Low Change	116.67%
All Time Low Date	2023-04-17
ATR	0.03
Beta	-0.17
Beta1y	-0.37
Beta2y	-0.22
Ch YTD	52.94
High	0.26
High52	0.26
High52 Date	2026-04-27
High52ch	0%
Low	0.19
Low52	0.16
Low52 Date	2026-02-27
Low52ch	67.74%
RSI	59.15
RSI Monthly	58.72
RSI Weekly	0
Sharpe ratio	2.09x
Sortino ratio	4.55
Tr YTD	52.94
Tr1m	30%
Tr1w	-0%
Tr3m	52.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -3.8M
Operating margin	-319.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,848,000%
Net Borrowing	1,559,804.1
Shares Insiders	0.89%
Shares Out	84,900,000

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,875x
Ch1m	30
Ch1w	-0
Ch1y	73.33
Ch3m	52.94
Ch3y	116.7
Ch6m	73.33
Change	0%
Change From Open	36.84
Close	0
Depreciation Amortization	265,207.7
Dollar Volume	2,340
Earnings Date	2026-05-20
EBIT	CAD -3.8M
EBITDA	CAD -3.5M
EPS	CAD -0.08
F Score	1
Financing CF	3,474,418
Fiscal Year End	December
Income Tax	CAD 26,051
Investing CF	973,495
Is Primary Listing	1
Last Report Date	2025-12-31
Ma20	0.19
Ma20ch	39.41%
Net CF	2,171,854
Next Earnings Date	2026-05-20
Open	0.19
Position In Range	100
Relative Volume	0.83x
Revenue	1,173,679x
SBC By Revenue	44.86x
Share Based Comp	526,510
Tax By Revenue	2.22x
Tr6m	73.33%
Volume	9,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/NTLX pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/NTLX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/NTLX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TSXV/NTLX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

-0.17

Less volatile than the market

Sharpe ratio

2.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/NTLX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/NTLX stock rating?

tsxv/NTLX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/NTLX analysis?

The full report lives at /stocks/tsxv/NTLX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/NTLX?

The latest report frames tsxv/NTLX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/NTLX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.